Cargando…
Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection
Genome-edited human pluripotent stem cells (hPSCs) have broad applications in disease modeling, drug discovery, and regenerative medicine. We present and characterize a robust method for rapid, scarless introduction or correction of disease-associated variants in hPSCs using CRISPR/Cas9. Utilizing n...
Autores principales: | Steyer, Benjamin, Bu, Qian, Cory, Evan, Jiang, Keer, Duong, Stella, Sinha, Divya, Steltzer, Stephanie, Gamm, David, Chang, Qiang, Saha, Krishanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830934/ https://www.ncbi.nlm.nih.gov/pubmed/29307579 http://dx.doi.org/10.1016/j.stemcr.2017.12.004 |
Ejemplares similares
-
Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
por: Cabrera-Cabrera, Florencia, et al.
Publicado: (2023) -
A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease
por: Hazelbaker, Dane Z., et al.
Publicado: (2017) -
Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus
por: D’Souza, Saritha S., et al.
Publicado: (2022) -
CRISPR Co-Editing Strategy for Scarless Homology-Directed Genome Editing
por: Reuven, Nina, et al.
Publicado: (2021) -
Optimization of scarless human stem cell genome editing
por: Yang, Luhan, et al.
Publicado: (2013)